LPAR1 and breast carcinoma: Mechanistically, lysophosphatidic acid (LPA1), a bioactive lipid that promotes cancer progression and bone metastasis, stimulates miR-21 expression in breast cancer cells via a LPA1/Pi3K/ZEB1-dependent signalling pathway [19].